- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06441201
Acute Gastrointestinal Bleeding Peripheral Pulse Volume Changes
December 4, 2025 updated by: Jad P. AbiMansour, Mayo Clinic
Peripheral Pulse Volume Changes in Acute Gastrointestinal Bleeding
The purpose and aim of this study are to compare changes in pulse volume to non-invasively predict active bleeding or high-risk stigmata in patients undergoing a gastrointestinal endoscopy to assess feasibility of the flow meter clinically.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The maximum change in volume of a limb segment during the cardiac cycle - pulse volume - will be monitored non-invasively along with standard vitals in patients with a suspected gastrointestinal bleed undergoing endoscopy.
Pulse volume and vitals will be collected prior to and following endoscopy up to the point of dismissal from the endoscopy unit so that the data may be correlated with the endoscopic and clinical findings.
Study Type
Observational
Enrollment (Actual)
13
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Subjects undergoing emergent endoscopic evaluation for active gastrointestinal bleeding at Mayo Clinic, Rochester, Minnesota.
Description
Inclusion Criteria:
- Adults (age >18yr) undergoing emergent endoscopy for active GI bleeding.
Exclusion Criteria:
- Patients with pre-existing heart failure (ejection fraction <40%), cardiac rhythm abnormalities and peripheral vascular disease.
- Patients with underlying implanted cardiac electrical devices and spinal cord stimulators.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Gastrointestinal Bleeding Peripheral Pulse Volume
Subject undergoing an emergency endoscopic evaluation for active gastrointestinal bleeding will have their peripheral pulse volumes monitored using a pulse flowmeter throughout the procedure and 2 hours after the procedure.
|
Measures peripheral pulse volumes by an electrode applied non-invasively to the lower extremity (left or right) at the beginning of the endoscopic evaluation for the duration of the procedure, and up to 2 hours after the completion of the procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in peripheral pulse volume with and without active bleeding
Time Frame: Baseline, approximately 2 hours post endoscopy
|
Peripheral pulse volume as measured by pulse flowmeter (uL/cm) pre and post endoscopic evaluation
|
Baseline, approximately 2 hours post endoscopy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Andrew Storm, MD, Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 13, 2024
Primary Completion (Actual)
September 22, 2025
Study Completion (Actual)
September 22, 2025
Study Registration Dates
First Submitted
May 29, 2024
First Submitted That Met QC Criteria
May 29, 2024
First Posted (Actual)
June 4, 2024
Study Record Updates
Last Update Posted (Actual)
December 11, 2025
Last Update Submitted That Met QC Criteria
December 4, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-005579
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on GastroIntestinal Bleeding
-
Ottawa Hospital Research InstituteRecruitingGastroIntestinal Bleeding | Anticoagulant-induced BleedingCanada
-
Waihong ChungUnknownMetoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy (MANPURSE)Upper Gastrointestinal Bleeding | Gastro Intestinal BleedingUnited States
-
Next Biomedical Co., Ltd.Not yet recruitingLower Gastrointestinal Bleeding | Diverticular BleedingKorea, Republic of
-
Tanta UniversityRecruitingCirrhosis | Variceal Bleeding | Upper Gastrointestinal Bleeding (UGIB)Egypt
-
Boston Children's HospitalBaylor College of Medicine; Children's Hospital of Philadelphia; Ann & Robert... and other collaboratorsRecruitingUpper Gastrointestinal Bleeding | Gastro Intestinal BleedingUnited States
-
National University of SingaporeRecruitingGastroIntestinal BleedingSingapore
-
Next Biomedical Co., Ltd.CompletedGastroIntestinal BleedingKorea, Republic of
-
Chinese University of Hong KongBeijing Friendship Hospital; The First Affiliated Hospital of Soochow University and other collaboratorsCompletedAcute Upper Gastrointestinal Bleeding | Tumor BleedingHong Kong, China, Australia
-
Assiut UniversityNot yet recruitingLower Gastrointestinal Bleeding
-
Universidad Autonoma de Nuevo LeonCompletedUpper Gastrointestinal BleedingMexico
Clinical Trials on Pulse flowmeter
-
OridionHerzog HospitalCompleted
-
Hennepin Healthcare Research InstituteCompletedRespiratory Failure
-
Children's Mercy Hospital Kansas CityBaylor University; University of Missouri, Kansas City; LifespanCompletedHypoxia | BronchiolitisUnited States
-
Amplitude Vascular Systems, Inc.RecruitingCoronary Arterial Disease (CAD)New Zealand, Australia
-
Amplitude Vascular Systems, Inc.Active, not recruitingPeripheral Arterial Disease (PAD)United States
-
University of Colorado, BoulderEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMultiple SclerosisUnited States
-
The First Affiliated Hospital with Nanjing Medical...CompletedRosacea | Pulsed Dye LaserChina
-
GE HealthcareCompletedClinical Indication for a Head MRIUnited States
-
William Beaumont HospitalsCompletedAsthma in Children | Respiratory Disease | Bronchiolitis Acute | Pneumonia in ChildrenUnited States
-
University of CopenhagenKU LeuvenCompleted